ViacomCBS (NASDAQ:VIAC) has been a costly disappointment for some investors in 2021. Enthusiasm over the company’s newly-announced streaming plans paired with Reddit-fueled retail investors drove VIAC stock past $100 three weeks into March. That was a 174% gain in under four months. Source: Jer123 / Shutterstock.com A catastrophic crash then saw shares lose half their
0 Comments
A bit of positive news included in Carnival’s (NYSE:CCL) second-quarter results lifted CCL  stock in late September. But even as the world appears on track to get “back to normal,” you may not want to buy Carnival’s shares at its present levels. There’s a good chance that the cruise line operator’s results will fully bounce
0 Comments
Listen to Preston’s podcast about studying billionaires here: https://itunes.apple.com/us/podcast/the-investors-podcast/id928933489 Jeff Bezos has been hailed as the richest man in the world, inching out long-time titleholder and Microsoft co-founder Bill Gates. The majority of his earnings came from his online shopping retail site Amazon.com with record-breaking profits from Amazon Prime Day. Huge portions also stemmed from
0 Comments
Here’s a rare opportunity for you. A “next-generation Medicare Advantage insurer,” Clover Health (NASDAQ:CLOV) operates in a high-potential market, providing health care access to seniors and other patient demographics. Yet, CLOV stock is trading at a surprisingly low price. Source: Shutterstock Currently, this stock has landed gently at a strong support level. So, it might be
0 Comments
Plug Power (NASDAQ:PLUG), the hydrogen fuel cell company, was somehow able to raise more than $3.4 billion in two different tranches in January and February 2021. The company sold $1.6 billion of PLUG stock at $29.29 in February to a subsidiary of SK Holdings, the third-largest conglomerate in South Korea. Source: Shutterstock Additionally, it managed
0 Comments
Ross Ulbricht (born 1984) is a former darknet market operator most famous for creating and running the Silk Road market. He was arrested in 2013, and two years later a Manhattan federal jury found him guilty on seven charges including conspiracy to launder money, conspiracy to commit computer hacking, conspiracy to traffic narcotics by the means of the internet,
0 Comments
After rising over $100 briefly this year, Cassava Sciences (NASDAQ:SAVA) stock is struggling to rebound. A long document written by the lawyer of a short-seller sent SAVA stock lower. The document challenged the accuracy of some of Cassava’s clinical results Source: Atthapon Raksthaput / Shutterstock.com Cassava has two major clinical studies underway. The top-line data
0 Comments